Three different strengths of generic Solodyn (minocycline) are currently available; the rest remain protected by a patent until February 2018 at the earliest, provided there are no outstanding lawsuits or other patents. There is a common misconception that the terms "generic name" and "generic version" mean the same thing. They do not. "Generic name" often refers to the active ingredient of a drug.
Solodyn® (minocycline hydrochloride) is a prescription antibiotic medication used to treat moderate-to-severe forms of acne. It belongs to a group of antibiotics called tetracyclines.
Solodyn is made by WellSpring Pharmaceutical Canada Corp. for Medicis Pharmaceutical Corporation. Some strengths of Solodyn tablets are protected by patents that prevent any generic versions from being sold in the United States. Other strengths are available in generic form.
Generic Solodyn is available in the following strengths:
- Minocycline 45 mg tablets
- Minocycline 90 mg tablets
- Minocycline 135 mg tablets.
The 55-mg, 80-mg, 105-mg, and 115-mg tablets are not yet available in generic form.
Generic Solodyn is made by a few companies, including Mylan Pharmaceuticals, Inc., Sandoz, and Teva Pharmaceutical Industries, Ltd.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic versions of Solodyn currently available have an "AB" rating, meaning they should be equivalent to Solodyn.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.